PHF23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.62550001131723E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.75039999559002E-08 |
Normal-vs-Stage2 |
2.59780000000376E-06 |
Normal-vs-Stage3 |
1.0913000003665E-07 |
Normal-vs-Stage4 |
1.92140000021546E-07 |
Stage1-vs-Stage2 |
2.442600E-01 |
Stage1-vs-Stage3 |
1.759440E-01 |
Stage1-vs-Stage4 |
3.009800E-01 |
Stage2-vs-Stage3 |
9.329800E-01 |
Stage2-vs-Stage4 |
7.021200E-01 |
Stage3-vs-Stage4 |
7.395400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.12580003284324E-10 |
Normal-vs-AfricanAmerican |
5.165600E-04 |
Normal-vs-Asian |
8.063600E-01 |
Caucasian-vs-AfricanAmerican |
2.641800E-01 |
Caucasian-vs-Asian |
5.474000E-02 |
AfricanAmerican-vs-Asian |
1.848780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.44149947323547E-10 |
Normal-vs-Female |
1.50989999999629E-05 |
Male-vs-Female |
1.171620E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.20189999999842E-05 |
Normal-vs-Age(41-60Yrs) |
1.28759999995509E-07 |
Normal-vs-Age(61-80Yrs) |
6.4861005455441E-10 |
Normal-vs-Age(81-100Yrs) |
2.696500E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.313800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.966000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.059200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.076400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.319200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.424600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.542960E-01 |
Normal-vs-Grade 2 |
1.77059999995066E-08 |
Normal-vs-Grade 3 |
8.34470004207333E-09 |
Normal-vs-Grade 4 |
2.00989999998846E-06 |
Grade 1-vs-Grade 2 |
2.478000E-01 |
Grade 1-vs-Grade 3 |
2.080800E-01 |
Grade 1-vs-Grade 4 |
2.482200E-01 |
Grade 2-vs-Grade 3 |
2.932200E-01 |
Grade 2-vs-Grade 4 |
7.518600E-01 |
Grade 3-vs-Grade 4 |
6.510200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.83680000001674E-06 |
Normal-vs-ccB subtype |
7.23570092731052E-11 |
ccA subtype-vs-ccB subtype |
4.796500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.44480000185965E-08 |
Normal-vs-N1 |
3.755800E-03 |
N0-vs-N1 |
9.376200E-01 |
|
|